JP2024519943A5 - - Google Patents
Info
- Publication number
- JP2024519943A5 JP2024519943A5 JP2023572071A JP2023572071A JP2024519943A5 JP 2024519943 A5 JP2024519943 A5 JP 2024519943A5 JP 2023572071 A JP2023572071 A JP 2023572071A JP 2023572071 A JP2023572071 A JP 2023572071A JP 2024519943 A5 JP2024519943 A5 JP 2024519943A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- baff
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/094605 | 2021-05-19 | ||
| CN2021094605 | 2021-05-19 | ||
| PCT/CN2022/093782 WO2022242710A1 (zh) | 2021-05-19 | 2022-05-19 | 一种特异性识别baff-r的嵌合抗原受体分子及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024519943A JP2024519943A (ja) | 2024-05-21 |
| JP2024519943A5 true JP2024519943A5 (enExample) | 2024-09-05 |
| JP7901840B2 JP7901840B2 (ja) | 2026-08-07 |
Family
ID=84060535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572071A Active JP7901840B2 (ja) | 2021-05-19 | 2022-05-19 | Ｂａｆｆ－ｒを特異的に認識するキメラ抗原受容体分子及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250268939A1 (enExample) |
| EP (1) | EP4342913B1 (enExample) |
| JP (1) | JP7901840B2 (enExample) |
| CN (1) | CN115368473A (enExample) |
| TW (1) | TW202300520A (enExample) |
| WO (1) | WO2022242710A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4786496A1 (en) * | 2023-09-28 | 2026-08-05 | Nanjing Iaso Biotechnology Co., Ltd. | Fully-human antibody and car-t cell targeting baff-r and use thereof |
| CN119241730B (zh) * | 2024-12-09 | 2025-03-04 | 天津医科大学总医院空港医院 | 一种分泌il10靶向baffr嵌合抗原受体、car-t细胞和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| DE69233528T2 (de) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| CN101851291B (zh) * | 2010-02-09 | 2011-10-26 | 中国人民解放军第四军医大学 | 一种抗人baff单克隆抗体的重链和轻链可变区 |
| MA42895A (fr) * | 2015-07-15 | 2018-05-23 | Juno Therapeutics Inc | Cellules modifiées pour thérapie cellulaire adoptive |
| EP3464371B1 (en) * | 2016-06-06 | 2026-07-29 | City of Hope | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof |
| US11136405B2 (en) * | 2016-06-06 | 2021-10-05 | Board Of Regents, The Unviersity Of Texas System | BAFF-R antibodies and uses thereof |
| SG11202008008UA (en) * | 2018-02-21 | 2020-09-29 | Univ Texas | Universal antigen presenting cells and uses thereof |
| WO2021163989A1 (en) | 2020-02-21 | 2021-08-26 | Yinnuolai Biotech Ltd. | Anti-baff receptor antibodies and uses thereof |
-
2022
- 2022-05-19 EP EP22804030.9A patent/EP4342913B1/en active Active
- 2022-05-19 WO PCT/CN2022/093782 patent/WO2022242710A1/zh not_active Ceased
- 2022-05-19 US US18/513,330 patent/US20250268939A1/en active Pending
- 2022-05-19 TW TW111118769A patent/TW202300520A/zh unknown
- 2022-05-19 CN CN202210546011.4A patent/CN115368473A/zh active Pending
- 2022-05-19 JP JP2023572071A patent/JP7901840B2/ja active Active